MedMira
MedMira Announces the appointment of Vice President of Commercial Operations
Halifax, Nova Scotia, October 3, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) today announced the appointment of Nicole Crenshaw as...
top of page
MedMira
13. Aug.5 Min. Lesezeit
Kopie der klinischen Studien mit dem Multiplo® Complete Syphilis (TP/nTP)-Antikörpertest beginnen - ein potenzieller Wendepunkt zur Bewältigung der Syphilis-Gesundheitskrise in Kanada
Halifax, Nova Scotia, 13. August 2024 – Heute gibt MedMira Inc. (MedMira) (TSXV: MIR) bekannt, dass es umfassende klinische Studien für...
MedMira
30. Apr.2 Min. Lesezeit
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their...
MedMira
19. Apr.1 Min. Lesezeit
Innovation made easy
With MedMira's patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our...
MedMira
13. März4 Min. Lesezeit
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent...
MedMira
1. Feb.3 Min. Lesezeit
Corporate Update on Clinical Evaluation of MedMira’s Products
Halifax, Nova Scotia,1 February, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to provide an update on the ongoing review...
bottom of page